EUVIMEDEUVIMED entdecken
Open Access

Cerebrospinal Fluid Mononuclear Cell Phenotype and Activation Predictors of 2-Week and 1-Year Survival Among Persons With HIV-Associated Cryptococcal Meningitis

Morris K Rutakingirwa iD, Kenneth Ssebambulidde iD, Samuel Okurut, Richard Kwizera iD, Martin Nabwana iD, Jane Gakuru iD, Jane Francis Ndyetukira iD, Suzan Mulwana, Lydia Nankungu, Kizza K Tadeo, Abdu K Musubire iD, David R Boulware iD und 1 weitere

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiaf449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Morris K Rutakingirwa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda. Hauptthemen laut MEDLINE: Meningitis, Cryptococcal, HIV Infections, Leukocytes, Mononuclear, Cerebrospinal Fluid. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, FIC NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite efforts to optimize therapy for HIV-associated cryptococcal meningitis (CM), survival outcomes remain poor. It is unclear how the cerebrospinal fluid (CSF) cellular immune phenotype and activation contribute to 2-week and 1-year survival following CM.

Methods

We compared baseline CSF mononuclear cell phenotype and activation among adults with HIV-associated CM who died within 2 weeks of CM diagnosis to survivors who were alive at 1 year. The activated CSF T lymphocytes, CD14+ monocytes, and CD56+ natural killer cells were determined from freshly collected CSF using Cytek Aurora Spectroflo cytometry. Quantitative CSF soluble cryptococcal antigen (CrAg) titer from frozen CSF at baseline and 1 year was determined using CrAg lateral flow assay. Data were analyzed using STATA version 9.

Results

Compared to survivors, participants who died within 2 weeks had significantly lower absolute CSF CD8+ T cells at baseline. For every 10% increase in PD-1 expression at baseline, the relative risk of 2-week mortality increased by 20%–60%. CSF CD14+ monocytes among those who died demonstrated low HLA-DR+ and high CD163+ expression compared to survivors. We noted a significant reduction in the median CSF CrAg titer from 1:2560 at baseline to 1:5 at 1 year (P < .0001) with 8 of 21 (38%) participants testing negative for CSF CrAg.

Conclusions

Expression of CD163 on CD14+ macrophages and immune exhaustion of CSF mononuclear cells at baseline are associated with an increased risk of early mortality in CM. After 1 year of treatment, approximately 4 in 10 patients with CM have a negative CSF CrAg.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Meningitis, CryptococcalHIV InfectionsLeukocytes, MononuclearCerebrospinal FluidAIDS-Related Opportunistic InfectionsHumansMaleAdultFemaleMiddle AgedPhenotypeMonocytesKiller Cells, NaturalAntigens, Fungal

Stichwörter der Autor:innen

HIVcell activationcryptococcal antigen titercryptococcal meningitisimmune responsesmortality

Substanzen

Antigens, Fungal

Autor:innen und Institutionen

  • Department of Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Department of Research, Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Data Management, Makerere University-John Hopkins University Research Collaboration, Kampala, Uganda.
  • Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.

ORCID-Profile: Morris K Rutakingirwa, Kenneth Ssebambulidde, Richard Kwizera, Martin Nabwana, Jane Gakuru, Jane Francis Ndyetukira, Abdu K Musubire, David R Boulware, David B Meya

Förderung

  • NIH HHS
  • FIC NIH HHS
  • NINDS NIH HHS
  • National Institutes of Health

Zitieren

APA

Rutakingirwa, M. K., Ssebambulidde, K., Okurut, S., Kwizera, R., Nabwana, M., Gakuru, J., Ndyetukira, J. F., Mulwana, S., Nankungu, L., Tadeo, K. K., Musubire, A. K., Boulware, D. R., & Meya, D. B. (2025). Cerebrospinal Fluid Mononuclear Cell Phenotype and Activation Predictors of 2-Week and 1-Year Survival Among Persons With HIV-Associated Cryptococcal Meningitis. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf449

Vancouver

Rutakingirwa MK, Ssebambulidde K, Okurut S, Kwizera R, Nabwana M, Gakuru J, et al. Cerebrospinal Fluid Mononuclear Cell Phenotype and Activation Predictors of 2-Week and 1-Year Survival Among Persons With HIV-Associated Cryptococcal Meningitis. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf449

BibTeX
@article{Rutakingirwa2025,
  author = {Rutakingirwa, Morris K and Ssebambulidde, Kenneth and Okurut, Samuel and Kwizera, Richard and Nabwana, Martin and Gakuru, Jane and Ndyetukira, Jane Francis and Mulwana, Suzan and Nankungu, Lydia and Tadeo, Kizza K and Musubire, Abdu K and Boulware, David R and Meya, David B},
  title = {Cerebrospinal Fluid Mononuclear Cell Phenotype and Activation Predictors of 2-Week and 1-Year Survival Among Persons With HIV-Associated Cryptococcal Meningitis},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiaf449}
}
Kostenlos starten →